2-[3-(2-methoxy-5-nitrophenyl)ureido]-N-(4-chlorophenyl)-2-phenylacetamide | 672962-54-8

• 分子结构分类: 有机化合物 - 有机酸及其衍生物 - 羧酸及其衍生物
• 英文名称: 2-[3-(2-methoxy-5-nitrophenyl)ureido]-N-(4-chlorophenyl)-2-phenylacetamide
• 英文别名: N-(4-chlorophenyl)-2-[(2-methoxy-5-nitrophenyl)carbamoylamino]-2-phenylacetamide
• CAS: 672962-54-8
• 化学式: C₂₂H₁₉ClN₄O₅
• 分子量: 454.87
• InChiKey: HQUIDGBAVPDHSQ-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  4
• 重原子数：
  32
• 可旋转键数：
  6
• 环数：
  3.0
• sp3杂化的碳原子比例：
  0.09
• 拓扑面积：
  125
• 氢给体数：
  3
• 氢受体数：
  5

文献信息

• Arylglycine derivatives and their use as glycine transport inhibitors
  申请人：NPS Allelix Corporation

  公开号：US20040152741A1

  公开（公告）日：2004-08-05

  The present invention relates to compounds of Formula 1, 1 and salts solvates and hydrates thereof. The invention further relates to pharmaceutical compositions containing said compounds and methods of treating neurological, neuropsychiatric, and gastrointestinal disorders using said compounds.

  本发明涉及化合物1的盐、溶剂和水合物，以及含有该化合物的制药组合物和使用该化合物治疗神经、神经精神和胃肠疾病的方法。
• [EN] ARYLGLYCINE DERIVATIVES AND THEIR USE AS GLYCINE TRANSPORT INHIBITORS<br/>[FR] DERIVES D'ARYLGLYCINE ET LEUR UTILISATION COMME INHIBITEURS DU TRANSPORT DE LA GLYCINE
  申请人：NPS ALLELIX CORP

  公开号：WO2004022528A2

  公开（公告）日：2004-03-18

  The present invention relates to compounds of Formula (I), and salts solvates and hydrates thereof. The invention further relates to pharmaceutical compositions containing said compounds and methods of treating neurological, neuropsychiatric, and gastrointestinal disorders using said compounds.